Clinical Trials Insight: 700032115
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2010
At a glance
- Drugs MBX 2982 (Primary)
- Indications Type 2 diabetes mellitus; Various toxicities
- Focus Adverse reactions
- Sponsors Metabolex
- 22 Jun 2010 Status changed from recruiting to completed, as reported in a Metabolex media release.
- 02 Apr 2008 New trial record.